Imaging3 sells $1M in stocks, warrants

Two institutional investors have agreed to purchase $1 million worth of Imaging3 common stock and warrants. The securities purchase agreement, which is expected to close by Oct. 14, includes the sale of approximately 4.59 million Imaging3 shares at a 20 percent discount from the  Oct. 1 closing price.

The sale also includes Series A-C warrants for optional purchases of nearly 1.5 million shares over the next five years, with share prices fixed between $0.22 and $0.27.

Imaging3, which provides technology medical imaging devices, said that the proceeds will provide the company with one year worth of working capital. The Burbank, Calif.-based company agreed not to use the proceeds to satisfy debt, redeem securities or in connection with any litigation involving Imaging3.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.